CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells
Fanconi anemia (FA) is an inherited condition characterized by impaired DNA repair, physical anomalies, bone marrow failure, and increased incidence of malignancy. Gene editing holds great potential to precisely correct the underlying genetic cause such that gene expression remains under the endogen...
Main Authors: | Karolina Skvarova Kramarzova, Mark J. Osborn, Beau R. Webber, Anthony P. DeFeo, Amber N. McElroy, Chong Jai Kim, Jakub Tolar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/6/1269 |
Similar Items
-
Aldehyde genotoxicity underlies haematopoietic stem cell depletion in Fanconi anaemia
by: Garaycoechea Amoroso, Juan Ignacio
Published: (2014) -
Monoubiquitination by the human Fanconi anemia core complex clamps FANCI:FANCD2 on DNA in filamentous arrays
by: Winnie Tan, et al.
Published: (2020-03-01) -
Anemia de Fanconi y embarazo: una combinación inusual Fanconi`s anemia and pregnancy: an unusual combination
by: Carlos Escalante-Gómez, et al.
Published: (2008-06-01) -
FANCD2 and DNA Damage
by: Manoj Nepal, et al.
Published: (2017-08-01) -
Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia
by: Ricardo Errazquin, et al.
Published: (2021-04-01)